Choose other brokers are suggested as alternative brokers based upon administration problems and/or adverse effect profile.  Zidovudine coupled with lamivudine is the alternative NRTI backbone but is connected to far more hematologic toxicity. Lopinavir/ritonavir is an alternate PI agent with established safety but reveals bigger gastrointestinal